Z
Zymeworks Inc.
ZYME · NASDAQ · Healthcare · 1.8B
Price · close
$28.67
+7.90% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
8.0×
Enterprise value / EBITDAEV/EBITDA
-31.1×
Free cash flow yieldFCF yield
-1.6%
Return on equityROE
-30.2%
Operating margin
-87.3%
Net debt / EBITDAbalance-sheet strength
0.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.